Human papillomavirus infection and autoimmune disorders: a tertiary center experience.


Journal

Pathogens and disease
ISSN: 2049-632X
Titre abrégé: Pathog Dis
Pays: United States
ID NLM: 101595366

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 05 03 2019
accepted: 27 04 2019
pubmed: 30 4 2019
medline: 12 3 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

This study aimed to investigate the relationship between HPV and autoimmune disorders. We retrospectively evaluated 62 women who had HPV-DNA positivity in terms of autoimmune disorders (autoimmune antibody positivity, chronic inflammatory diseases and autoimmune diseases). The patients were divided into two groups according to autoimmune disorder positivity (autoimmune positive (n = 30), autoimmune negative (n = 32)) and compared with each other in terms of single and multiple HPV-DNA types, high and low-risk HPV-DNA types, and Pap smear findings. We determined that 48.4% of the HPV-DNA positive patients had autoimmune disorders. We found that 15 of 62 (24.2%) women had more than one type of HPV and HPV type 16 was the dominant type in this study (58.2%). A total of 27.4% of HPV-DNA positive patients had abnormal cytological findings. There was no statistically significant difference between autoimmune groups in terms of the presence of high-risk HPV types, multiple HPV types and abnormal cytological findings (P = 0.531, P = 0.558 and P = 0.234, respectively). The prevalence of autoimmune disorders was high among HPV-DNA positive women. On the other hand, the rate of high-risk HPV type positivity, multiple HPV infections and cytopathological findings were similar between the autoimmune positive and negative groups.

Identifiants

pubmed: 31034015
pii: 5481523
doi: 10.1093/femspd/ftz028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© FEMS 2019.

Auteurs

Hanife Guler Donmez (HG)

Department of Biology, Faculty of Science, Hacettepe University, 06800 Beytepe, Ankara, Turkey.

Atakan Tanacan (A)

Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey.

Canan Unal (C)

Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey.

Erdem Fadiloglu (E)

Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey.

Sevgen Celik Onder (SC)

Department of Pathology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey.

Oytun Portakal (O)

Department of Medical Biochemistry, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey.

M Sinan Beksac (MS)

Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH